Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420080 · ClinicalTrials.gov registry record
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
A clinical trial, sponsored by Jazz Pharmaceuticals.
- Terminated
- Registry status
- 100
- Enrollment target
NCT02420080 is a clinical trial that was terminated before completion, run by Jazz Pharmaceuticals. The registered enrollment target is 100 participants.
The verdict
NCT02420080 was terminated before completion, sponsored by Jazz Pharmaceuticals.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The objective is data collection to determine background rates of adenovirus (AdV) progression and mortality in subjects with Adenovirus (AdV) infection and/or disease.
Interventions
- DRUG Brincidofovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02420080
The ClinicalTrials.gov registry entry for NCT02420080 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brincidofovir is the first listed.
NCT02420080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02420080 about?
NCT02420080 is a clinical study titled "A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304". The objective is data collection to determine background rates of adenovirus (AdV) progression and mortality in subjects with Adenovirus (AdV) infection and/or disease.
What is the current status of trial NCT02420080?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2015-02. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02420080?
The interventions under investigation include: Brincidofovir (DRUG).
Who is sponsoring clinical trial NCT02420080?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.